Metformin/rosiglitazone

MISSION &#174 esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence.

MISSION &#174 esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence.

MISSION &#174 esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence.

MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence.

MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence.

An activator of the GTP-binding protein Rab7 (EC₅₀ = 77.6 nM) that demonstrates selectivity against the related GTPases cdc42, Ras, Rab-2A, and Rac1 (EC₅₀s = 588.8, 346.7, 158.5, and 794.3 nM, respectively).

An activator of the GTP-binding protein Rab7 (EC₅₀ = 77.6 nM) that demonstrates selectivity against the related GTPases cdc42, Ras, Rab-2A, and Rac1 (EC₅₀s = 588.8, 346.7, 158.5, and 794.3 nM, respectively).

An activator of the GTP-binding protein Rab7 (EC₅₀ = 77.6 nM) that demonstrates selectivity against the related GTPases cdc42, Ras, Rab-2A, and Rac1 (EC₅₀s = 588.8, 346.7, 158.5, and 794.3 nM, respectively).

An activator of the GTP-binding protein Rab7 (EC₅₀ = 77.6 nM) that demonstrates selectivity against the related GTPases cdc42, Ras, Rab-2A, and Rac1 (EC₅₀s = 588.8, 346.7, 158.5, and 794.3 nM, respectively).

An activator of the GTP-binding protein Rab7 (EC₅₀ = 77.6 nM) that demonstrates selectivity against the related GTPases cdc42, Ras, Rab-2A, and Rac1 (EC₅₀s = 588.8, 346.7, 158.5, and 794.3 nM, respectively).

An activator of the GTP-binding protein Rab7 (EC₅₀ = 77.6 nM) that demonstrates selectivity against the related GTPases cdc42, Ras, Rab-2A, and Rac1 (EC₅₀s = 588.8, 346.7, 158.5, and 794.3 nM, respectively).

A potent inverse agonist of LRH-1 (IC₅₀ = 320 nM) with maximum efficacy of 40% repression inactive at the related SF1 transcriptional activator alters the expression of haptoglobin, SAA1, and SAA4, induces the death of MDA-MB-231 breast